| __timestamp | Galapagos NV | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 2917513 |
| Thursday, January 1, 2015 | 20309000 | 7878291 |
| Friday, January 1, 2016 | 16945000 | 8366794 |
| Sunday, January 1, 2017 | 20559000 | 6610381 |
| Monday, January 1, 2018 | 29641000 | 6556000 |
| Tuesday, January 1, 2019 | 88258000 | 6930000 |
| Wednesday, January 1, 2020 | 162170000 | 8758000 |
| Friday, January 1, 2021 | 167218000 | 10806000 |
| Saturday, January 1, 2022 | 239528000 | 9844000 |
| Sunday, January 1, 2023 | 94252000 | 13481000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Soleno Therapeutics, Inc. and Galapagos NV from 2014 to 2023. Over this period, Galapagos NV consistently outspent Soleno Therapeutics, with its SG&A expenses peaking in 2022 at nearly 240% higher than its 2014 levels. In contrast, Soleno Therapeutics maintained a more stable expenditure, with a modest increase of around 360% over the same period. This disparity highlights the differing strategic approaches of these companies, with Galapagos NV potentially investing more aggressively in growth and expansion. Understanding these trends provides valuable insights into the financial strategies of biotech firms and their impact on long-term sustainability.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Bio-Techne Corporation vs Galapagos NV: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights